Benzinga - Thu, 25 Mar 2021 16:03:09 -0400
Benzinga - Thu, 25 Mar 2021 04:02:57 -0400
Benzinga - Wed, 24 Mar 2021 10:04:05 -0400
Benzinga - Mon, 22 Mar 2021 09:49:18 -0400
Benzinga - Wed, 10 Mar 2021 14:36:43 -0400
Benzinga - Wed, 10 Mar 2021 09:09:37 -0400
Benzinga - Wed, 10 Mar 2021 08:19:45 -0400
Benzinga - Wed, 10 Mar 2021 06:19:51 -0400
Benzinga - Tue, 09 Mar 2021 13:19:34 -0400
Benzinga - Tue, 09 Mar 2021 08:00:33 -0400
Benzinga - Mon, 08 Mar 2021 14:09:14 -0400
Benzinga - Mon, 08 Mar 2021 13:54:59 -0400
load more
Sector: Health Care.Industry: Biotechnology
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS-0.310-0.380 -0.0700
REV1.300M1.352M52.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
OPGNOpGen0%102.2M

OpGen Company Questions & Answers

Q

How do I buy OpGen (OPGN) stock?

A

You can purchase shares of OpGen (NASDAQ: OPGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are OpGen's (OPGN) main competitors?

A

Other companies in OpGen’s space includes: PolarityTE (NASDAQ:PTE), Celyad Oncology (NASDAQ:CYAD) and Lumos Pharma (NASDAQ:LUMO).

Q

What is the target price for OpGen?

A

The latest price target for OpGen (NASDAQ: OPGN) was reported by Alliance Global Partners on 2021-03-02. The analyst firm set a price target for 7.00 expecting OPGN to rise to within 12 months (a possible 162.17% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is OpGen (OPGN) stock ?

A

The stock price for OpGen (NASDAQ: OPGN) is $2.67 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next OpGen (OPGN) dividend?

A

There are no upcoming dividends for OpGen.

Q

When is OpGen (NASDAQ:OPGN) reporting earnings?

A
OpGen’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for OPGN?

A

There is no upcoming split for OpGen.